SOW
KLDO

State of Wyoming’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

State of Wyoming’s Portfolio KLDO Stock Details KLDO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,236
Closed -$5K – 2126
2021
Q4 		$5K Buy
2,236
+138
+7% +$562 ﹤0.01% 1729
2021
Q3 		$11K Sell
2,098
-14
-0.7% -$87 0.01% 1022
2021
Q2 		$16K Buy
+2,112
New +$15K 0.01% 966

Other funds holding KLDO

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State of Wyoming's KLDO Position: Q1 2022 in Review

State of Wyoming sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q1 2022, closing a stake of 2,236 shares — an estimated $5K sold.

State of Wyoming first reported a position in KLDO in Q2 2021 and held it in 3 quarters. The position peaked at $16K in Q2 2021. 63 funds tracked by Wall St. Rank hold KLDO as of Q1 2022.

  • State of Wyoming reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • State of Wyoming sold 2,236 Kaleido Biosciences, Inc. Common Stock shares in Q1 2022, an estimated $5K.
  • State of Wyoming first reported a position in Kaleido Biosciences, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
  • State of Wyoming's Kaleido Biosciences, Inc. Common Stock position peaked at $16K in Q2 2021.
  • 63 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q1 2022.

Based on State of Wyoming's 13F filing for Q1 2022, filed 13 May 2022.